Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP - 1) Inhibitor in Diabetic Complications

類似資料

• Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP-1) Inhibitor for Diabetic Complications
  著者:: Kaveri Adki
• Preclinical Studies on Daidzein in the Treatment of Diabetic Complications
  著者:: Laddha Ankit P.
  出版事項: (2021)
• Targeting NF-κβ by natural Products in the Management of Vascular Complications of Diabetes
  著者:: Suryavanshi Sachin Vilas
  出版事項: (2021)
• Study of Naturally Occurring Flavones in the Treatment of Vascular Complications of Diabetes
  著者:: Parkar Nishad
  出版事項: (2014)
• Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications
  著者:: Oza Manisha
  出版事項: (2019)